CompoAtlas

Huang qi jian pi wan

Food supplement declared in France, declaration No 2020-4-1107, decision dated 21 April 2020

Huang qi jian pi wan, from Calebasse, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Astragalus membranaceus 0.6 g per day, Dioscorea polystachya 0.6 g per day, Atractylodes macrocephala 0.3 g per day, Crataegus laevigata 0.3 g per day, Ziziphus jujuba 0.3 g per day. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
Calebasse
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
3 g
Not recommended (according to the manufacturer)
Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking anticoagulants, Taking diabetes medication, Prolonged use
Objectives stated by the manufacturer (these are not authorised claims)
Digestion

Declaration 301777, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Astragalus membranaceus MoenchRacineExtrait sec aqueux0.6 g
Dioscorea polystachya Turcz.RhizomeExtrait sec aqueux0.6 g
Atractylodes macrocephala Koidz.RhizomeExtrait sec aqueux0.3 g
Crataegus laevigata (Poir.) DC.FruitExtrait sec aqueux0.3 g
Ziziphus jujuba Mill.FruitExtrait sec aqueux0.3 g
Morus alba L.FeuilleExtrait sec aqueux0.3 g
Raphanus raphanistrum subsp. sativus (L.) DominGraineExtrait sec aqueux0.3 g

Additives

E1204

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Consultez votre médecin ou votre pharmacien en cas d’usage concomitant d'anticoagulant ou de traitement contre le diabète.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Astragalus membranaceus Moench
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    Sources cited by Health Canada (2)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Health Canada monograph dated 30 May 2025

  • Crataegus laevigata (Poir.) DC.
    Read the warning, when it applies and the studies cited

    Hawthorn

    Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Huang qi jian pi wan: composition and regulation”, https://compoatlas.com/en/supplements/products/301777-huang-qi-jian-pi-wan, updated 15 November 2026.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line